A Back Bay resident and Boston University School of Medicine professor has received a grant to study new therapies to treat Alzheimer’s disease.
David Harris, MD, PhD, chairman and professor of biochemistry at BUSM received a Massachusetts Neuroscience Consortium Award that will allow Harris and his team to explore new therapeutic targets for Alzheimer’s disease.
Harris’ laboratory investigates the molecular and cellular mechanisms underlying prion diseases and Alzheimer’s disease, two classes of human neurodegenerative disorders.
The two-year, $250,000 grant will help Harris develop a therapy for Alzheimer’s disease that targets a newly recognized molecular pathway responsible for neurodegeneration.
“This award will significantly enhance our ability to develop improved therapies for Alzheimer’s disease by allowing us to interact with industry partners, which is an important element of drug development,” Harris in a statement.
Boston University School of Medicine said in a statement announcing the grant that current treatments are largely ineffective and do not halt the cognitive decline associated with the disease, but with this approach, the school said, drug compounds have the potential to overcome some of the limitations of existing medications.
E-mail Kaiser at Johanna.firstname.lastname@example.org. For more news about your city, town, neighborhood, or campus, visit boston.com’s Your Town homepage.